4-vinylphenol has been researched along with cyclin d1 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, L; Fung, KP; Jiang, L; Kwok, HF; Lau, CB; Lee, JK; Leung, HW; Leung, PC; Wong, EC; Wong, YL; Yu, H; Yue, GG | 1 |
1 other study(ies) available for 4-vinylphenol and cyclin d1
| Article | Year |
|---|---|
Novel PI3K/AKT targeting anti-angiogenic activities of 4-vinylphenol, a new therapeutic potential of a well-known styrene metabolite.
Topics: Angiogenesis Inhibitors; Animals; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclin B1; Cyclin D1; Down-Regulation; Drugs, Chinese Herbal; Extracellular Matrix Proteins; Extracellular Signal-Regulated MAP Kinases; Female; Hedyotis; Human Umbilical Vein Endothelial Cells; Humans; Male; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neovascularization, Pathologic; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Phenols; Phosphatidylinositol 3-Kinases; Phosphorylation; Plant Extracts; Proto-Oncogene Proteins c-akt; Styrenes; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2; Zebrafish | 2015 |